ASTH (ASTH) Misses Q4 EPS by 25c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Astrana Health, Inc (ASTH) PT Lowered to $49 at BofA Securities
March 3, 2025 1:40 PM ESTBofA Securities analyst Adam ROn lowered the price target on Astrana Health, Inc (NASDAQ: ASTH) to $49.00 (from $55.00) while maintaining a Buy rating.
The analyst comments "ASTH reported somewhat mixed 4Q results. Despite roughly hitting consensus EBITDA estimates, the company missed its... More
